Overview of Dr. Landau
Dr. Heather Landau is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from SUNY Upstate Medical University and has been in practice 16 years. Dr. Landau accepts several types of health insurance, listed below. She is one of 494 doctors at Memorial Sloan Kettering Cancer Center and one of 90 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She has more than 100 publications and over 500 citings.
Office
1275 York Ave
Box 8
New York, NY 10021
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
- University of ColoradoResidency, Internal Medicine, 2001 - 2004
- SUNY Upstate Medical UniversityClass of 2001
Certifications & Licensure
- FL State Medical License 2021 - Present
- CT State Medical License 2023 - 2025
- NJ State Medical License 2021 - 2025
- NY State Medical License 2003 - 2025
- NH State Medical License 2024 - 2024
- CO State Medical License 2003 - 2005
Clinical Trials
- Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma Start of enrollment: 2006 Nov 01
- Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis Start of enrollment: 2007 Feb 01
- Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma Start of enrollment: 2007 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsA prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation.Michael Scordo, Gunjan L Shah, Peter A Adintori, Andrea Knezevic, Sean M Devlin
Cancer. 2022-11-01 - 136 citationsOff-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantationSusan E. Prockop, Ekaterina Doubrovina, Stephanie Suser, Glenn Heller, Juliet N. Barker
The Journal of Clinical Investigation. 2020-02-03 - 39 citationsRisk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myelomaTomas Radivoyevitch, Robert M. Dean, Bronwen E. Shaw, Ruta Brazauskas, Heather R. Tecca
Leukemia Research. 2018-11-01
Journal Articles
- Novel Iatrogenic Amyloidosis Caused by Peptide Drug Liraglutide: A Clinical Mimic of AL AmyloidosisHeather J Landau, Ahmet Dogan, Haematologica
Abstracts/Posters
- A Phase 1/2 Study to Assess Safety and Dose of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Patients with Light Chain (AL) Amyloi...Heather J Landau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Primary Results from the Phase 3 Tourmaline-AL1 Trial of Ixazomib-Dexamethasone Versus PhysicianÍs Choice of Therapy in Patients (Pts) with Relapsed/Refractory Primary...Heather J Landau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Results of the Phase 3 VITAL Study of NEOD001 (Birtamimab) Plus Standard of Care in Patients with Light Chain (AL) Amyloidosis Suggest Survival Benefit for Mayo Stage ...Heather J Landau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Untangling Amyloidosis 201961st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- MRD-Response Driven Phase I/II Study for Newly Diagnosed Multiple Myeloma Patients Using Higher Doses of Twice-Weekly Carfilzomib (45 and 56 mg/m2) in Combination with...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Dysgeusia Is Associated with Higher Melphalan Pharmacokinetic Levels and Results in Poorer Caloric Intake and Worse Symptom Burden after Autologous Stem Cell Transplan...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Tom Brokaw: Cancer Interrupts His Lucky LifeNovember 13th, 2015
- Emerging Concepts in Multiple MyelomaOctober 29th, 2015
- A Study to Identify Barriers to Cellular Therapies for People with Plasma Cell DisordersNovember 14th, 2023
- Join now to see all
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California CaliforniaCare HMO
BCBS California PowerSelect HMO
BCBS California PPO
BCBS Florida BlueCare HMO
BCBS Florida BlueSelect
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
Blue Shield CA Local Access Plus HMO
Blue Shield California HMO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMOEmpire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
Health Net California Large Group PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
Pacificare HMO
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: